Pharmaceutical Retailers
- 134.633
- -4.159-3.00%
Walgreens Boots Alliance Is Maintained at Overweight by JP Morgan
Walgreens Boots Alliance Analyst Ratings
J.P. Morgan Maintains Walgreens Boots Alliance(WBA.US) With Buy Rating, Cuts Target Price to $15
Analysts' Opinions Are Mixed on These Healthcare Stocks: Walgreens Boots Alliance (WBA), 2seventy Bio (TSVT) and Repare Therapeutics (RPTX)
Evercore ISI Sticks to Their Hold Rating for Walgreens Boots Alliance (WBA)
Evercore ISI Lowers Price Target on Walgreens Boots Alliance to $7.50 From $10, Keeps In Line Rating
Walgreens Boots Alliance (WBA) Receives a Sell From Barclays
PetMed Express Analyst Ratings
Petmed Express: Hold Rating With Cautious Outlook Amidst Management Changes and Competitive Challenges
Barclays Maintains Walgreens Boots Alliance(WBA.US) With Sell Rating, Maintains Target Price $7
Analysts Offer Insights on Healthcare Companies: R1 RCM (RCM) and Walgreens Boots Alliance (WBA)
HSBC Adjusts Price Target on Walgreens Boots Alliance to $7 From $11
Walgreens Boots Alliance Analyst Ratings
Barclays Adjusts Price Target on Walgreens Boots Alliance to $7 From $11
Baptista Research Upgrades Walgreens Boots Alliance to Outperform From Hold, Price Target Is $13.70
Walgreens Boots Alliance Analyst Ratings
Walgreens Boots Alliance (WBA) Receives a Hold From RBC Capital
RBC Cuts Price Target on Walgreens Boots Alliance to $13 From $22, Keeps Sector Perform Rating
JPMorgan Adjusts Price Target on Walgreens Boots Alliance to $20 From $30, Maintains Overweight Rating
Walgreens Boots Alliance Analyst Ratings